| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/BBRC.2001.5532 |
| P698 | PubMed publication ID | 11549290 |
| P2093 | author name string | Gutkind JS | |
| Miyazaki H | |||
| Sodhi A | |||
| Montaner S | |||
| P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 292-300 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. | |
| P478 | volume | 287 |
| Q33556370 | 1α, 25-Dihydroxyvitamin D regulates hypoxia-inducible factor-1α in untransformed and Harvey-ras transfected breast epithelial cells |
| Q46036046 | A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. |
| Q38846154 | Acidic tumor microenvironment in human melanoma |
| Q37230670 | Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression. |
| Q53635273 | Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. |
| Q28240136 | Colorectal cancer: genetics of development and metastasis |
| Q45929048 | Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases. |
| Q48402816 | Cooperative expression of survival p-ERK and p-Akt signals in rat brain neurons after transient MCAO. |
| Q40737536 | Copper-induced vascular endothelial growth factor expression and wound healing |
| Q38989123 | Direct phosphorylation events involved in HIF-α regulation: the role of GSK-3β. |
| Q78860218 | Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes |
| Q34300226 | Genomic structure and promoter characterization of the human Sprouty4 gene, a novel regulator of lung morphogenesis |
| Q40273686 | Global gene expression analysis of ERK5 and ERK1/2 signaling reveals a role for HIF-1 in ERK5-mediated responses. |
| Q35856898 | Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner |
| Q37660947 | Glycogen synthase kinase-3β and cathepsin B in diabetic endothelial progenitor cell dysfunction: an old player finds a new partner |
| Q24669693 | Gut mucosal healing: is the science relevant? |
| Q36999089 | HIF gene expression in cancer therapy |
| Q36822204 | HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer |
| Q28578172 | HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons |
| Q35550217 | HIF-1 as a target for drug development |
| Q37883900 | HIF-1α in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders. |
| Q30539170 | HIF1α and HIF2α independently activate SRC to promote melanoma metastases |
| Q45903004 | Honokiol inhibits hypoxia-inducible factor-1 pathway. |
| Q34614394 | Human tumor-associated viruses and new insights into the molecular mechanisms of cancer |
| Q33598377 | Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells |
| Q26768230 | Hypoxia-Inducible Factors (HIFs) and Phosphorylation: Impact on Stability, Localization, and Transactivity |
| Q39669709 | Hypoxia-Inducible Factors: Post-translational Crosstalk of Signaling Pathways |
| Q36137705 | Hypoxia-induced angiogenesis: good and evil |
| Q35677642 | Hypoxia-inducible factor-1 and oncogenic signalling |
| Q35740230 | Hypoxia-inducible factor-1 in tumour angiogenesis. |
| Q33763812 | Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling |
| Q38998235 | In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growt |
| Q36178164 | Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer |
| Q36158687 | Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition |
| Q74541466 | Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells |
| Q42237844 | Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growth |
| Q33437371 | Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1alpha in hypoxia |
| Q39192021 | Linking oxygen to time: the bidirectional interaction between the hypoxic signaling pathway and the circadian clock |
| Q34177495 | MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300 |
| Q37620679 | Metabolism addiction in pancreatic cancer |
| Q89769994 | Modulation of bone turnover aberration: A target for management of primary osteoporosis in experimental rat model |
| Q37605343 | Molecular mechanisms underlying chronic inflammation-associated cancers |
| Q35521969 | Neuroprotective effects of DAHP and Triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activation |
| Q40619559 | Nitric Oxide Induces Hypoxia-inducible Factor 1 Activation That Is Dependent on MAPK and Phosphatidylinositol 3-Kinase Signaling |
| Q77653264 | Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway |
| Q37036699 | Phosphatidylinositol 3-kinase pathway regulates hypoxia-inducible factor-1 to protect from intestinal injury during necrotizing enterocolitis. |
| Q33292543 | Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter |
| Q35449481 | Physical and functional interactions between Runx2 and HIF-1α induce vascular endothelial growth factor gene expression |
| Q52614479 | Protective effects of PI3KCG gene on acute myocardial infarction. |
| Q36642721 | Redox regulation of the hypoxia-inducible factor |
| Q34979759 | Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes |
| Q44452025 | Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells |
| Q34790987 | Responding to hypoxia: lessons from a model cell line |
| Q35668936 | Roles of main pro- and anti-angiogenic factors in tumor angiogenesis |
| Q40184757 | Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. |
| Q36999104 | Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. |
| Q28854271 | Systemic propranolol reduces b-wave amplitude in the ERG and increases IGF-1 receptor phosphorylation in rat retina |
| Q37387690 | TNFalpha induces HIF-1alpha expression through activation of IKKbeta |
| Q35814821 | Therapeutic angiogenesis using vascular endothelial growth factor |
| Q39901693 | Thrombin up-regulates vascular endothelial growth factor in experimental gliomas. |
| Q39155786 | Vitamin D analogue TX 527 down-regulates the NF-κB pathway and controls the proliferation of endothelial cells transformed by Kaposi sarcoma herpesvirus |
| Q37086022 | mTOR pathway in renal cell carcinoma |
Search more.